Skip to main content
ABSTRACT & COMMENTARY

Cerebral Embolic Protection Device Disappoints in TAVR/Stroke Trial

In this largest-to-date randomized trial of stroke prevention in transcatheter aortic valve replacement patients, use of the Sentinel cerebral embolic protection device did not significantly affect the incidence of periprocedural stroke.